DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) like sitagliptin and linagliptin are well-absorbed oral agents that work through a different mechanism to GLP-1 agonists
At that pace, many would be expected to return to their starting weight within 18 months
GLP-1 Microdosing has been shown to optimize metabolism, improve cardiovascular health, reduce inflammation, and promote cellular health, often with reduced or no side effects
Tirzepatide benefits compared to Semaglutide: Greater Weight Loss: Often leads to more weight loss than Semaglutide Dual Hormone Action: Targets two hormones (GLP-1 and GIP) for better appetite and blood sugar control Better Blood Sugar Management: More effective at lowering A1C levels in many cases Reduces Risk of Diabetes: Helps prevent type 2 diabetes in people with obesity or prediabetes Supports Heart Health: May improve cholesterol, blood pressure, and reduce inflammation Boosts Metabolism: Helps the body process and burn fat more efficiently Easy Weekly Injections: Simple, once-a-week dosing Why choose Tirzepatide over Semaglutide
Older people are often detected to have a more portent vitamin B12 deficiency, even in cases where they do not suffer from pernicious anemia
Were dedicated to using research to deepen our understanding of GLP-1s, obesity care, and metabolic healthand using these insights to help more patients achieve their goals